This training will generate a sense of security of security in the performance of medical practice, which will help you grow personally and professionally"

In 2018, more than 18 million tumors were registered worldwide, according to figures handled by the Spanish Society of Medical Oncology (SEOM). Moreover, these figures are expected to continue to rise to 29.5 million in 2040. In Spain alone, more than 270,000 cases will be diagnosed in 2019, the most frequent being colon and rectum, prostate, breast, lung, and urinary bladder.

This postgraduate diploma in Oncology. Specialty in Malignant Tumors allows you to gain in-depth knowledge of the effective techniques and resources being used for oncological diagnosis. 

Early detection of tumors can help make treatments more effective and lead to more successful cases among patients, thus reducing the number of deaths. But medical advances are also extremely important, as is the updating of professionals to be able to implement these advances in their patients.

The program has been designed and developed by oncology specialists, ranked among the best in medical excellence, who have provided students with the most advanced knowledge, experience and practical cases to create a program following the highest quality criteria available in the market. 

In this way, we will review the generalities and risk factors of oncology patients and the molecular basis of cancer. In this postgraduate diploma, physicians will focus on the study of tumors related to the organs of the thoracic cavity, skin, gastrointestinal tract and hemolymphoid tumors.

Update your knowledge with the postgraduate diploma in Oncology. Specialty in Malignant Tumors”

This postgraduate diploma in Oncology. Specialty in Malignant Tumors has the most complete and up-to-date program on the market The most important features include:

• The development of dozens of case studies presented by experts in oncology in Oncology. Specialty in Malignant Tumors
• The graphic, schematic, and eminently practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• The latest information on Oncology. Specialty in Malignant Tumors
• Practical exercises where the self-assessment process can be carried out to improve learning
• A special emphasis on innovative methodologies in Oncology. Specialty in Malignant Tumors
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is Accessible from any Fixed or Portable device with an Internet Connection

This postgraduate diploma may be the best investment you can make in selecting a refresher program for two reasons: in addition to updating your knowledge in Oncology. Specialty in Malignant Tumors, you will obtain a postgraduate diploma issued by TECH Technological University"

Its teaching staff includes professionals belonging to the field of Oncology. Specialty in Malignant Tumors, who bring to this training the experience of their work, in addition to recognized specialists belonging to reference societies and prestigious universities. and prestigious universities.

Its multimedia content, developed with the latest educational technology, will enable the professional to contextual and situated learning, i.e. a simulated environment that will provide immersive learning immersive learning programmed to train in real situations.

This program's design is based on problem-based learning, by means of which the professional must try to solve the different professional practice situations that arise during the course. For this purpose, the specialist will be assisted by an innovative interactive video system developed by renowned experts in the field of oncology. 
by recognized experts in the field of oncology. Specializing in malignant tumors, and with great medical experience. 

Its teaching staff includes renowned specialists from prestigious universities"

Take the opportunity to learn about the latest advances in Oncology. Specialty in Malignant Tumors and improve the care of your patients"

This online postgraduate diploma in Oncology. Specialty in Malignant Tumors is oriented to facilitate the performance of the professional dedicated to medicine with the latest advances and newest treatments in the sector. With the latest advances and most innovative treatments in the sector. 

This postgraduate diploma is designed for you to update your knowledge in Oncology. Specialty in Malignant Tumors, with the use of the latest educational technology of the latest educational technology, to contribute with quality and safety to decision making"

General Objective

• The main goal of this training in Oncology is to provide the professional with a deep scientific knowledge about oncology, especially of a deep scientific knowledge on oncology, especially addressing malignant tumors, as well as the most advanced treatments and advances that are allowing to save the lives of people affected by this disease

Specific Objectives

• Recognize the characteristics of malignant neoplasms, their classification according a their histogenesis, as well as aspects related to their biological behavior
• Acquire up-to-date knowledge on cancer epidemiological data worldwide
• Learn about screening methods in at-risk populations to diagnose cancerous lesions early
• Recognize the environmental and occupational factors (mutagenic agents) that are directly and indirectly involved in cancer, and the carcinogenic capacity of some toxic substances found in food
• Relate DNA and RNA viruses known to cause cancer in humans
• Expose the mechanisms by which viruses are able to subjugate the normal activity of host cytoplasmic proteins, affecting key points in the control of the cell cycle, cell growth and differentiation, causing severe alterations in cell growth and cancer development
• Recognize the role of H. pylori bacteria in the pathogenesis of gastric cancer
• Understand cancer as a genetic disease resulting from mutations that accumulate in genes that are critical for the growth and development of somatic cells
• Describe the genes associated with cancer, and the importance of DNA analysis to identify individuals, detect predisposing gene polymorphisms, analyze mutations, and establish the diagnosis of cancer as a genetic disease
• Recognize the susceptibility genes involved in breast, lung, thyroid, colon, skin, bone, pancreatic, and neuroblastoma cancers, and by what mechanism they participate in tumorigenesis
• Know the symptoms and signs that are most frequently related to cancer, as well as the different systems for the staging of tumor disease and their importance
• Know the phases of the cell cycle, the critical control points, as well as the genes involved in its regulation
• Recognize the important role of cell cycle checkpoints and DNA repair systems in maintaining the fidelity and integrity of genome replication and repair, and regulating cell cycle dynamics
• Explain the positive and negative feedback regulatory processes that contribute to cell cycle progression, and the significance of negative controls on cell cycle progression that are present during development, differentiation, senescence, and cell death, which play an important role in preventing tumorigenesis
• Identify the difference in gene expression between normal tissue and tumor tissue
• Know the stages involved in the transformation of a normal cell to a malignant cell
• Recognize the malignant phenotype as the result of a characteristic pattern of gene expression, alterations in the function of the human genome, leading to aberrant growth, dedifferentiation, invasion and metastasis
• Characterize the different genes involved in cell cycle regulation (growth-promoting genes, growth-inhibiting genes, genes that regulate apoptosis and genes that repair damaged DNA), and the mutations that alter them
• Explain the key role that oncogenes may play in the development of cancer by directing mechanisms that lead to the development of neoplasms
• Know tumor suppressor genes as cytoplasmic components capable of reversing the tumor phenotype; proteins that control the cell cycle, proliferation, and differentiation
• Identify epigenetic aberrations (DNA methylation with silencing of gene expression, and histone modifications that can enhance or dampen expression), which contribute to the malignant properties of cells
• Recognize the role of epigenetic changes in malignant phenotype, including gene expression, control of differentiation, and sensitivity and resistance to anticancer therapy
• Know the genes and proteins associated with malignant diseases and their utility as tumor markers to define a particular entity, its diagnosis, staging, prognosis, and screening in the population
• Know and apply the different technologies used to analyze the gene expression profile of neoplasms to identify clinical and biological aspects that are difficult to determine by histopathological examination. Its principles, advantages, and disadvantages
• Explain the importance of gene expression profiling for the application of different treatment protocols and the response to them among histologically similar tumors
• Recognize the importance of gene expression profiling in the new classifications of malignant tumors associated with prognosis and response to treatment
• Carry out an up-to-date review of the morphological knowledge and molecular pathology of the most frequent types of epithelial and non-epithelial thoracic cavity tumors
• Describe the relevant aspects of the diagnosis, prognosis, and differential diagnosis of the main epithelial and mesenchymal lung tumors
• Review relevant aspects of the diagnosis of lesions of each segment of the mediastinum
• Develop molecular diagnostic algorithms for lung and pleural cancer
• Acquire in-depth knowledge of cutaneous tumor pathology, learning and reviewing the morphological characteristics of the most frequent tumors
• Establish clinical-pathological correlation
• Sample management, from sample collection and preservation, to conventional staining, immunohistochemistry, and special laboratory and molecular pathology techniques
• Acquire detailed knowledge of the molecular classification of stomach and colorectal cancer
• Acquire in-depth knowledge about carcinogenesis and morpho-molecular diagnosis of GISTs
• An in-depth look at the role of precursor lesions of the biliopancreatic system
• Gain more in-depth knowledge of the different types of systemic lymphomas and mature B and T neoplasms
• Address the difficulties in the histopathological diagnosis of Hodgkins lymphoma
• Learn about the morphological and molecular differences between benign and malignant lesions of the hemato-lymphoid system

A unique, key and decisive training experience to boost your professional development"